Let's discuss facial masking as a symptom of Parkinson's
Hypomimia, or facial masking, is a potential early diagnostic tool that should be discussed more, says columnist Mollie Lombardi.| Parkinson's News Today
Clario and the University of Oxford are testing a wearable device to see how effective it is at tracking subtle changes in Parkinson’s disease, with the aim of improving clinical […] The post Wearable device aims to help researchers track Parkinson’s appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
For the first time, scientists have managed to visualize tiny protein clumps in the brain that are thought to trigger Parkinson’s disease, opening the door for new insights into how […] The post Scientists create first visualization of tiny Parkinson’s protein clumps appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
October is a busy month in my household. We celebrate both my husband’s birthday and our wedding anniversary. It’s been 19 years this year, and I can say that we […] The post Parkinson’s puts our ‘in sickness and in health’ vows to the test appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Shape Therapeutics’ SHP-201, an experimental gene therapy for Parkinson’s disease, significantly reduced the levels of alpha-synuclein — a protein that plays a key role in the development of the neurodegenerative […] The post Parkinson’s gene therapy reduced alpha-synuclein in animal models appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
WTX-607, an oral small molecule being developed by Wavebreak, binds to and blocks the formation of small alpha-synuclein protein clumps — toxic aggregates linked to nerve damage in Parkinson’s disease […] The post Drug blocks toxic alpha-synuclein clumps in human brain tissue in lab appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
An experimental therapy being developed by Herantis Pharma for Parkinson’s disease was well tolerated and able to penetrate the blood-brain barrier (BBB), a semipermeable membrane that prevents certain substances, including […] The post Parkinson’s therapy is tolerated well, clearing path for Phase 2 trial appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
ARV-102, an oral therapy Arvinas is developing for people with Parkinson’s disease, was shown to reach the brain — where it is needed — and to be safe and well […] The post Parkinson’s therapy ARV-102 able to reach brain, where needed: Study appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
If you are at all familiar with Parkinson’s disease, you’re probably aware of the importance of medication. It’s used for symptom control only, as there is no known cure or […] The post Tools to navigate a hospital stay with Parkinson’s disease appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
The oral therapy GT-02287, being developed by Gain Therapeutics for people with Parkinson’s disease with or without mutations in the GBA1 gene, was shown to ease motor symptoms and help […] The post GT-02287 safely eases Parkinson’s motor symptoms in study appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Hypomimia, or facial masking, is a potential early diagnostic tool that should be discussed more, says columnist Mollie Lombardi.| Parkinson's News Today
Patients preferred Medtronic’s Brainsense adaptive DBS to traditional, continuous DBS in a trial, which found Brainsense safe and effective.| Parkinson's News Today
The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
The nonprofit Healthwell Foundation has opened a fund to help offset Parkinson’s treatment costs for Medicare beneficiaries in the U.S.| Parkinson's News Today
Xingimaging and Synusight received a MFJJ grant to develop PET imaging technology that monitors toxic protein clumps in Parkinson's.| Parkinson's News Today
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
More U.S. patients will have access to a mobile app to track Parkinson's symptoms, as Neu Health joins an incubator program in Houston.| Parkinson's News Today
Advocates gathered in Washington to urge Congress to expand federal funding for Parkinson’s disease research at NIH.| Parkinson's News Today
Columnist Mary Beth Skylis shares instances where technology can support a better quality of life for Parkinson's disease patients.| Parkinson's News Today
A $697,000 MJFF grant and a renewed, five-year, $2.7 million NIH award will fund early Parkinson's research at the University of Wisconsin.| Parkinson's News Today
The Web's Daily Resource for Parkinson's News| Parkinson's News Today
The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Parkinson’s patients and their care partners found several aspects of a personalized fall prevention program effective, despite barriers.| Parkinson's News Today
Seal Rock has joined an MJFF initiative to develop therapies targeting the LRRK2 gene, which can contribute to Parkinson’s development.| Parkinson's News Today
Having metabolic syndrome, a cluster of abnormalities characterized by abdominal obesity and high blood sugar, may increase Parkinson's risk.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
Analyzing real-world patient data may help researchers better understand Parkinson’s causes, its early signs, and responses to therapy.| Parkinson's News Today
ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s, was found safe and well tolerated in healthy volunteers in a trial.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Parkinson's patients receiving brain stem cell transplant therapy may be able to take a less intensive immunosuppression regimen.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
A recent study confirmed columnist Mollie Lombardi's observations about the different ways women and men approach DBS surgery for Parkinson's.| Parkinson's News Today
In the first of a four-part series on deep brain stimulation for Parkinson's, columnist Mollie Lombardi describes her initial DBS surgery.| Parkinson's News Today
Blocking the stress sensor GADD45G in astrocytes — star-shaped cells that support neurons — may be a therapeutic strategy for Parkinson’s.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the...| Parkinson's News Today
Casma Therapeutics will develop CSM-101 as a potential oral treatment for Parkinson's disease and Gaucher disease.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Sleep disorders were mainly associated with Parkinson's motor symptoms and problems regulating involuntary bodily functions, a s tudy shows.| Parkinson's News Today
Michael S. Okun, MD, answers questions about deep brain stimulation for people with Parkinson's in our monthly "Expert Voices" series.| Parkinson's News Today
Growing up, columnist Jamie Askari tried to avoid being different, but her husband's early-onset Parkinson's diagnosis changed that.| Parkinson's News Today
Blood levels of 2 proteins in REM sleep behavior disorder patients linked with later finding of Parkinson's-like disease, Lewy body dementia.| Parkinson's News Today
Columnist Mollie Lombardi hopes she doesn't experience the Parkinson's dementia that her grandpa had to endure.| Parkinson's News Today
Read about physiotherapy and exercise programs, done under a specialist's guidance, to help maintain muscle strength and balance in Parkinson's patients.| Parkinson's News Today
Side-to-side eye movements reduced body sway in people with Parkinson's disease in a study of 10 people with Parkinson's and 11 without it.| Parkinson's News Today
Insightec's Exablate Neuro device is approved by the FDA for use by some Parkinson's patients with moderate-to-severe motor complications.| Parkinson's News Today
In a trial, once-daily buntanetap halted cognitive decline in early-stage Parkinson's and improved cognition in patients with mild dementia.| Parkinson's News Today
No description.| Parkinson's News Today
Parkinson’s patients show an inflammatory gut microbiome (bacterial population of the intestines) regardless of disease status or lifestyle.| Parkinson's News Today
Patricia Inacio is a science writer for Parkinson's News Today with a PhD in cell biology. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Poor hand grip strength was tied to a higher risk of developing Parkinson’s in a U.K. study, especially among those with genetic risk factors.| Parkinson's News Today
Rigidity refers to abnormal stiffness in the limbs or other body parts, which prevents muscles from stretching and relaxing.| Parkinson's News Today
Non-motor symptoms, ranging from depression to constipation, problems sleeping to cognitive changes, can be fairly common in Parkinson's.| Parkinson's News Today
Learn more about the two types of Parkinsonian tremor: resting tremors and action tremors, which about 70% of PD patients experience early on.| Parkinson's News Today
Bradykinesia is slowness or difficulty in body movement and is one of the early signs of Parkinson’s disease.| Parkinson's News Today
Most Parkinson's patients experience a range of walking difficulties, resulting in distinctive gait and balance problems.| Parkinson's News Today
Learn more about dyskinesia, the uncontrolled, involuntary movements that affects many Parkinson's disease patients.| Parkinson's News Today
The alpha-synuclein seed amplification assay, or alphaSyn-SAA, can detect Parkinson's disease with high accuracy, a new study reveals.| Parkinson's News Today
Columnist Mollie Lombardi shares how her early-onset Parkinson's disease diagnosis has affected her husband and their marriage.| Parkinson's News Today
When choosing members of your healthcare team, don't settle for just "OK," says columnist Christine Scheer. Advocating for yourself is key.| Parkinson's News Today
Marisa Wexler is a senior science writer for Parkinson's News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
A wide range of Parkinson's disease treatment options can help ease symptoms and make living with the disorder more manageable.| Parkinson's News Today
Focused ultrasound, a minimally invasive technology, will soon be available at Vanderbilt to treat essential tremor and Parkinson’s disease.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
No description.| Parkinson's News Today
While there's no test to confirm a Parkinson's diagnosis in its early stages, the disease can be detected based on a variety of symptoms.| Parkinson's News Today
There are a few surgical treatments for Parkinson's disease, but the most common surgery for PD is deep brain stimulation (DBS).| Parkinson's News Today
Columnist Mary Beth Skylis shares tips for positive coping skills that she encourages her dad, who has Parkinson's, to implement.| Parkinson's News Today
The Parkinson's Progression Markers Initiative, launched in 2010 to better understand and treat the disease, will recruit at sites in Canada.| Parkinson's News Today
Concerned by her dad's recent weight loss, columnist Mary Beth Skylis questions if Parkinson's symptoms or medications have played a role.| Parkinson's News Today
Category archive page for Columns.| Parkinson's News Today
Parkinson's disease symptoms affect both motor skills and nonmotor skills, and progress differently in each person.| Parkinson's News Today
The gut microbiome of Parkinson's patients shows substantial functional differences compared with that of healthy people, per a new study.| Parkinson's News Today
Lindsey Shapiro is a science writer for Parkinson's News Today with a PhD in neuroscience. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Learn more about cognitive impairment in parkinson's disease, which is a common non-motor symptom that affects both patients and caregivers.| Parkinson's News Today
The motor symptoms of Parkinson’s disease refer to those that affect the body’s movement and are grouped into primary and secondary motor symptoms.| Parkinson's News Today
Margarida Maia is a science writer for Parkinson's News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
The causes of Parkinson's disease can include a combination of genetic and environmental factors. Age and gender may also be risk factors.| Parkinson's News Today
Category archive page for News.| Parkinson's News Today
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
A history of upper gastrointestinal mucosal damage was associated with a 76% greater risk of subsequently developing Parkinson's disease.| Parkinson's News Today
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.| Parkinson's News Today
The FDA issued a letter encouraging the use of an alpha-synuclein assay to improve the efficiency of clinical trials in Parkinson's disease.| Parkinson's News Today
Regeneron joined the data syndication program for the LEARNS study that's assessing digital biomarkers for measuring Parkinson's progression.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
Understanding and identifying epigenetic changes in blood samples from people with Parkinson’s disease may help assess the risk of dementia.| Parkinson's News Today
The clinical trial is assessing the safety of Allyx Therapeutics' ALX-001 versus a placebo when given to adults twice daily for 28 days.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today
